Noven Recalls Minivelle Estradiol Patches Due to Defective Delivery System
Noven Pharmaceuticals is recalling Minivelle (estradiol) transdermal systems because the delivery system failed stability testing for peel force.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Noven Pharmaceuticals, Inc. is recalling 14,434 cartons of Minivelle (estradiol) 0.1 mg per day transdermal systems. The recall involves Lot #78618 with an expiration date of 05/2017. The product was distributed nationwide within the United States.
The recall was initiated because the delivery system was found to be out of specification for peel force from the release liner during stability testing at 18 months under 25C/60%RH conditions. This defect relates to the physical integrity of the patch's delivery mechanism.
Consumers who have this specific lot of Minivelle should stop using it and contact their healthcare provider or pharmacist for guidance. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The recalled product
- Product
- MINIVELLE (ESTRADIOL)
- Brand
- MINIVELLE
- Manufacturer
- Noven Pharmaceuticals, Inc.
- Category
- Drug — Transdermal Patch
- Affected units
- 14,434
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #:: 78618
- Exp. 05/2017
UPCs (1)
- 0368968665083
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MINIVELLE
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2021-04-28
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- SevereNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defect
FDA (Drugs) · 2018-10-03
- ModerateNoven Recalls Minivelle Estradiol Patches Due to Adhesive Defects
FDA (Drugs) · 2018-10-03
Same manufacturer · Noven Pharmaceuticals, Inc.
See all →- HighPrescription Dextroamphetamine Patches Recalled for Defective Adhesive System
FDA (Drugs) · 2024-11-27
- HighDaytrana methylphenidate patches recalled for defective delivery system
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Patches Recalled for Defective Transdermal Delivery System
FDA (Drugs) · 2023-03-29
- ModerateDaytrana Methylphenidate Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- HighDaytrana transdermal methylphenidate patches recalled for adhesive defect
FDA (Drugs) · 2022-12-07